Prognostic Factors of Patients With COVID-19

Chongqing Medical University1 site in 1 country201 target enrollmentMarch 1, 2020

ConditionsSARS-CoV-2 Outcome, Fatal

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: SARS-CoV-2
Sponsor: Chongqing Medical University
Enrollment: 201
Locations: 1
Primary Endpoint: all-cause mortality
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. Despite lower mortality rate, SARS-CoV-2 has killed more people than SARS and MERS and the number keeps growing. Epidemic studies have been well described clinical features of patients with COVID-19, with the disease severity being an independent predictor of poor outcome. However, there is still no research investigating the prognostic factors of patients with COVID-19.

Registry

clinicaltrials.gov

Start Date

March 1, 2020

End Date

March 13, 2020

Last Updated

6 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Chongqing Medical University

Responsible Party

Principal Investigator

Dongying Zhang

Clinical Professor

Chongqing Medical University

Eligibility Criteria

Inclusion Criteria

•Adult aged \>=18years old;
•Diagnosed with CONVID
•Diagnostic criteria including: Laboratory (RT-PCR) confirmed SARS-Cov-2 infection; CT of the lung conformed to the manifestation of viral pneumonia.
•Criteria for severe or critical ill conditions: Respiratory rate \>=30/min; or Rest SPO2\<=93%; or PaO2/FiO2\<=300mmHg.